A detailed history of Milestone Asset Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Milestone Asset Management, LLC holds 26,949 shares of EXEL stock, worth $902,252. This represents 0.16% of its overall portfolio holdings.

Number of Shares
26,949
Previous 25,946 3.87%
Holding current value
$902,252
Previous $583 Million 19.95%
% of portfolio
0.16%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$21.96 - $27.6 $22,025 - $27,682
1,003 Added 3.87%
26,949 $699 Million
Q2 2024

Jul 19, 2024

SELL
$20.34 - $23.73 $22,007 - $25,675
-1,082 Reduced 4.0%
25,946 $583 Million
Q1 2024

Apr 23, 2024

BUY
$20.17 - $23.93 $545,154 - $646,780
27,028 New
27,028 $641 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.8B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Milestone Asset Management, LLC Portfolio

Follow Milestone Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Milestone Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Milestone Asset Management, LLC with notifications on news.